[go: up one dir, main page]

AU2020900220A0 - Method of Treatment - Google Patents

Method of Treatment

Info

Publication number
AU2020900220A0
AU2020900220A0 AU2020900220A AU2020900220A AU2020900220A0 AU 2020900220 A0 AU2020900220 A0 AU 2020900220A0 AU 2020900220 A AU2020900220 A AU 2020900220A AU 2020900220 A AU2020900220 A AU 2020900220A AU 2020900220 A0 AU2020900220 A0 AU 2020900220A0
Authority
AU
Australia
Prior art keywords
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2020900220A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Murdoch University
Original Assignee
Murdoch University
Filing date
Publication date
Application filed by Murdoch University filed Critical Murdoch University
Publication of AU2020900220A0 publication Critical patent/AU2020900220A0/en
Priority to PCT/AU2021/050054 priority Critical patent/WO2021151153A1/en
Priority to CA3166000A priority patent/CA3166000A1/en
Priority to EP21747421.2A priority patent/EP4097235A4/en
Priority to US17/795,828 priority patent/US20230081388A1/en
Priority to AU2021213025A priority patent/AU2021213025A1/en
Abandoned legal-status Critical Current

Links

AU2020900220A 2020-01-28 2020-01-28 Method of Treatment Abandoned AU2020900220A0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
PCT/AU2021/050054 WO2021151153A1 (en) 2020-01-28 2021-01-28 Antisense oligomers and methods for treating parkin-related pathologies
CA3166000A CA3166000A1 (en) 2020-01-28 2021-01-28 Antisense oligomers and methods for treating parkin-related pathologies
EP21747421.2A EP4097235A4 (en) 2020-01-28 2021-01-28 ANTISENSE OLIGOMERS AND METHODS FOR TREATING PARKIN-ASSOCIATED PATHOLOGIES
US17/795,828 US20230081388A1 (en) 2020-01-28 2021-01-28 Antisense oligomers and methods for treating parkin-related pathologies
AU2021213025A AU2021213025A1 (en) 2020-01-28 2021-01-28 Antisense oligomers and methods for treating parkin-related pathologies

Publications (1)

Publication Number Publication Date
AU2020900220A0 true AU2020900220A0 (en) 2020-02-13

Family

ID=

Similar Documents

Publication Publication Date Title
EP4117728A4 (en) Method for treatment of covid-19-associated conditions
EP4143202A4 (en) Method of treating ship1-mediated diseases using pelorol derivatives
AU2021902405A0 (en) Method of treatment
AU2021900204A0 (en) Method of treatment
AU2020900433A0 (en) Method of treatment
AU2020900220A0 (en) Method of Treatment
AU2023903893A0 (en) Method of treatment
AU2023901658A0 (en) Method of Treatment
AU2023901529A0 (en) Method of Treatment
AU2023901341A0 (en) Method of Treatment
AU2023900427A0 (en) Method of treatment
AU2022903003A0 (en) Method of Treatment
AU2022902548A0 (en) Method of treatment
AU2022901083A0 (en) Method of Treatment
AU2021903030A0 (en) Methods of treatment
AU2021902512A0 (en) Methods of treatment
AU2021900789A0 (en) Methods of treatment
AU2020903332A0 (en) Methods of treatment
AU2020902585A0 (en) Methods of treatment
AU2023902382A0 (en) Methods of treatment
AU2020900580A0 (en) Methods of Treatment
AU2021900740A0 (en) Combination Methods of Treatment
AU2019903303A0 (en) Method of Treatment
AU2022903002A0 (en) Method of Treating
AU2019901742A0 (en) Method of treatment